Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients.

PubWeight™: 0.89‹?›

🔗 View Article (PMC 4062449)

Published in Ann Surg Treat Res on May 23, 2014

Authors

Kyeong Woon Choi1, Seong Woo Hong1, Yeo Goo Chang1, Woo Yong Lee1, Byungmo Lee1, In Wook Paik1, Hyucksang Lee1

Author Affiliations

1: Department of Surgery, Inje University Seoul Paik Hospital, Seoul, Korea.

Articles cited by this

Cancer-related inflammation. Nature (2008) 34.21

Acute-phase proteins and other systemic responses to inflammation. N Engl J Med (1999) 18.25

Inflammation and colon cancer. Gastroenterology (2010) 6.32

Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol (2005) 4.92

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol (2010) 4.83

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 3.64

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer (2003) 3.44

The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev (2012) 3.42

Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg (2007) 3.33

Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol (2012) 2.35

Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis (2007) 2.30

Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer (2001) 2.10

A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res (2006) 2.02

Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res (2009) 1.82

Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care (2005) 1.73

Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene. Proc Natl Acad Sci U S A (2005) 1.70

Use of aspirin postdiagnosis improves survival for colon cancer patients. Br J Cancer (2012) 1.54

Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma: a retrospective study of 398 Japanese patients. Am J Surg (2011) 1.19

Is C-reactive protein a prognostic factor of colorectal cancer? Dis Colon Rectum (2008) 1.04

Inflammation-based prognostic score as a predictor of postoperative gastric cancer recurrence. Anticancer Res (2012) 0.83